Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMW0H9Y)

Drug Name
KA2507 Drug Info
Indication
Disease Entry ICD 11 Status REF
Solid tumour/cancer 2A00-2F9Z Phase 1 [1]
Cross-matching ID
PubChem CID
117703516
TTD Drug ID
DMW0H9Y

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Patented Agent(s)
Download the Complete Related Drug List
Drug(s) Targeting Histone deacetylase 6 (HDAC6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Citarinostat DMQLODU Multiple myeloma 2A83 Phase 1 [1]
PMID29671355-Compound-62 DMWRS34 N. A. N. A. Patented [2]
PMID29671355-Compound-43 DMVPMWJ N. A. N. A. Patented [2]
PMID29671355-Compound-25 DMPV0KZ N. A. N. A. Patented [2]
PMID29671355-Compound-21 DMPJN0M N. A. N. A. Patented [2]
PMID29671355-Compound-31 DM3H78D N. A. N. A. Patented [2]
PMID29671355-Compound-56 DM0VBMI N. A. N. A. Patented [2]
PMID29671355-Compound-67 DM1RPL4 N. A. N. A. Patented [2]
PMID29671355-Compound-23 DMUBOEX N. A. N. A. Patented [2]
PMID29671355-Compound-44 DM80A3V N. A. N. A. Patented [2]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Histone deacetylase 6 (HDAC6) TT5ZKDI HDAC6_HUMAN Inhibitor [1]

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 HDAC inhibitors: a 2013-2017 patent survey.Expert Opin Ther Pat. 2018 Apr 19:1-17.